Waters Co. (NYSE:WAT) Shares Bought by Apollon Wealth Management LLC

Apollon Wealth Management LLC lifted its stake in shares of Waters Co. (NYSE:WAT) by 3.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,258 shares of the medical instruments supplier’s stock after buying an additional 109 shares during the period. Apollon Wealth Management LLC’s holdings in Waters were worth $1,173,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in shares of Waters by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 6,879,316 shares of the medical instruments supplier’s stock valued at $2,368,067,000 after acquiring an additional 41,654 shares during the period. GUARDCAP ASSET MANAGEMENT Ltd raised its position in Waters by 1.1% during the 1st quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 1,110,898 shares of the medical instruments supplier’s stock worth $382,404,000 after buying an additional 11,851 shares during the last quarter. Van ECK Associates Corp increased its holdings in shares of Waters by 1.0% in the 3rd quarter. Van ECK Associates Corp now owns 659,539 shares of the medical instruments supplier’s stock valued at $219,811,000 after purchasing an additional 6,647 shares in the last quarter. Principal Financial Group Inc. increased its holdings in shares of Waters by 70.7% in the 3rd quarter. Principal Financial Group Inc. now owns 656,019 shares of the medical instruments supplier’s stock valued at $236,095,000 after purchasing an additional 271,804 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in Waters by 21.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 448,304 shares of the medical instruments supplier’s stock valued at $130,053,000 after acquiring an additional 77,951 shares in the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Wall Street Analyst Weigh In

WAT has been the topic of several research analyst reports. Jefferies Financial Group raised shares of Waters from a “hold” rating to a “buy” rating and raised their target price for the stock from $355.00 to $415.00 in a research report on Tuesday, October 8th. Barclays upped their price target on shares of Waters from $330.00 to $360.00 and gave the stock an “underweight” rating in a research report on Monday, November 4th. TD Cowen upped their price target on shares of Waters from $363.00 to $410.00 and gave the company a “hold” rating in a report on Monday, November 4th. Cfra set a $389.00 price target on shares of Waters in a research report on Thursday, October 17th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on Waters from $310.00 to $325.00 and gave the company a “hold” rating in a report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $365.85.

Waters Stock Performance

NYSE:WAT opened at $376.72 on Friday. The company has a market capitalization of $22.37 billion, a P/E ratio of 35.95, a P/E/G ratio of 7.06 and a beta of 0.97. Waters Co. has a 1 year low of $258.89 and a 1 year high of $393.38. The company has a debt-to-equity ratio of 1.14, a current ratio of 2.02 and a quick ratio of 1.38. The business has a fifty day simple moving average of $350.16 and a two-hundred day simple moving average of $330.13.

Waters (NYSE:WAT) last issued its quarterly earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.68 by $0.25. Waters had a return on equity of 49.93% and a net margin of 21.43%. The firm had revenue of $740.30 million during the quarter, compared to analyst estimates of $712.99 million. During the same quarter in the previous year, the company posted $2.84 earnings per share. The company’s revenue was up 4.0% compared to the same quarter last year. On average, analysts expect that Waters Co. will post 11.79 earnings per share for the current year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.